MSFT
MSFT
$390.49+1.62%
Setup
No setup
Buy Zone
$394.04-$413.74
Sector
—
Industry
—
38
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
MSFT chart
Loading chart…
Overall Quality38
RS Rating
15
relative strength
Fundamentals
45
Weak fund-Q
Volume Demand
82
+7% vs avg
Technical Setup
50
4/8 checks
Industry/Theme
91
Computer Software-Enterprise
Trade Plan
Avoid
Entry
$394.04
Entry Zone
$394.04-$413.74
Stop / Risk
$362.52
RS Rating
15
Volume confirmed
Yes
Targets
$472.85 / $492.55
Breakout · IBD Setup
2 ✓ 6 ✗
Entry $394.04–$413.74Stop $362.52Target $472.85 / $492.55
Market regimeRange
Quality38
RS Rating15
Above 50-MA-4.2%
Above 200-MA-12.34%
VolumeConfirmed
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
38
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q45 · Weak
StatusAvoid
Stock Data
52-Week Range349 – 555
Price % Chg YTD-19.26%
Price % Chg 4wk-11.52%
50-Day Avg Vol39.5 Mil
P/E Ratio—
Market Cap$576B
Sector—
Industry—
Company Fundamentals
EPS % Chg (Qtr)—
Sales % Chg (Qtr)—
EPS Growth 5y—
Sales Growth 5y—
Annual ROE—
Gross Margin—
Operating Margin—
Net Margin—
Debt / Equity—
Setup levels
Current price
$390.49
Pivot
$394.04
Distance to buy
-29.7%
52-week range
349.21-555.46
Trigger evidence
No active trigger evidence available.
Financial health checks
0/0
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE—
Net margin—
Gross margin—
EPS growth q/q—
Sales growth q/q—
Debt / equity—
lower is better
Business quality
45
GradeWeak
EPS rating50
P/E—
Market cap$576B
Industry—
Technical checks
Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Pass
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
TRIM2026-06-2600:05:35
One of the mega-caps that has been a drag on the market, with money flowing out of it.
Signal history
Added to list
2026-06-27
Trigger date
—
Days on list
7
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.